Salvage and spike it. What to do when your GLP preclinical study raises questions.
“We needed to conduct the study perfectly to prove to the FDA that our technology really was safe and effective; we learned that we needed to engage the right partners to do that.” – Innoblative Co-Founder and CEO Tyler Wanke Innoblative seeks to change the game for intraoperative coagulation and ablation of soft tissue via…
